Navigation Links
Global Aptamers Market Technology Trend Analysis Market Report 2013-2018: Therapeutics, Diagnostics, Biosensors, Biomarker/Drug Discovery & Applications
Date:11/8/2013

DUBLIN, November 8, 2013 /PRNewswire/ --

Research and Markets
( http://www.researchandmarkets.com/research/tfh2m9/aptamers_market) has announced the addition of the "Global Aptamers Market Technology Trend Analysis Market Report 2013-2018" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)


The global aptamers market is valued at $287 million in 2013 and is expected to reach $2.1 billion by 2018.

Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018

Aptamers existed alongside antibodies for two decades, but their market potential was not utilized to even a fraction of the same degree. However, the achievement of Macugen has given a boost to the aptamer field. The list of promising aptamers in the clinical trials pipeline estimates that these synthetic chemical antibodies will soon surpass monoclonal antibodies in therapeutics, diagnosis, and imaging. With technological merits over antibodies, the aptamers market is poised to grow at par with antibodies in the next 10-15 years.

Though there are just approximately 60 companies (biotech and pharmaceutical) working on aptamers, there are quite a number of research groups focused on the diverse applications of aptamers, particularly in studying key target molecules involved in cardiovascular diseases, infectious diseases, and against viral antigens. Hundreds of research articles have been published and a large number of patents granted and filed for this technology.

As well as a discussion on the properties of aptamers in the technological analysis, the basics on nucleic acid aptamers, peptide aptamers and the SELEX method for their synthesis are also discussed. Research applications are specifically discussed regarding aptamers use in flow cytometry, reagents and assays, mass spectrometry and western blotting. In addition, a number of therapeutic targets that are validated by basic research have been displayed under the therapeutics application segment. The complete value chain of the aptamers market is schematically represented and the significance of each stakeholder has been briefed.

Furthermore this report assesses the investor climate by tracking the complete investor network and collecting data on funds/grants and investments made in aptamers. Insights on current and future technological investment trends have also been discussed. The adoption and developmental potential of the aptamers technology market has been discussed on a geographic basis, i.e. North America, Europe, Asia-Pacific, and Rest of the world, by taking select countries that are poised to have a greater market value during the forecast period.

Scope of the Report

By Application

- Therapeutics
- Diagnostics
- Biosensors
- Drug discovery
- Biomarker discovery
- Research applications

By Aptamer Type

- Nucleic acid aptamers
- Peptide aptamers

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Aptamers - Technology Landscape Analysis 

4 Aptamers - Market Landscape Analysis

5 Technology Investment Potential

6 Aptamers - Technology Adoption And Development Potential

7 Aptamers Competitive Landscape

8 Intellectual Property And Research Strength Analysis

9 Analyst Insights And Recommendations 

10 Company Profiles

- AM Biotechnologies, Llc
- Aptagen, LIC
- Aptamatrix, Inc
- Aptamer Sciences Inc
- Aptamer Solutions Ltd
- Aptares AG
- Aptusbiotech
- Base Pair Biotechnologies
- Bioapter SL
- Cd Genomics
- Integrated Dna Technologies, Inc
- Lucerna, Inc
- NOXXON Pharma AG
- Neoventures Biotechnology Inc
- OTC Biotech
- Ophthotech Corporation
- Pfizer
- Regado Biosciences, Inc
- Somalogic, Inc
- Trilink Biotechnologies, Inc
- Vivonics

For more information visit http://www.researchandmarkets.com/research/tfh2m9/aptamers_market

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Polymerase Chain Reaction (PCR) - Products/Tools - A Global Market Watch, 2009-2015
2. Global Positron Emission Tomography Market 2012-2016: Industry Analysis, Size, Share, Growth, Trends and Forecast New Research Report Available at MarketResearchReports.biz
3. Biopharmaceuticals - A Global Market Overview
4. Regado Biosciences, Inc. Appoints World-Renowned Leader in Cardiovascular Research and Former Global Head of Cardiovascular Diseases for Merck & Co., to Board of Directors
5. Analysis of Global Biochips Industry, 2012-2018
6. Clinical Research Site-Expert Johan Karlberg to Lead ACRES Global Network Development
7. TVM Capital Group Announces Two-pronged Global Investment Strategy with Renewed MENA Focus
8. Global In Vitro Fertilization Market 2012-2016: Industry Analysis, Size, Share, Growth, Trends and Forecast New Research Report Available at MarketResearchReports.biz
9. Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis
10. Global Biophotonics Market & OSS BSS Industry 2012-2016 Reports
11. BCC Research Publishes a New Report On Global Markets for Flow Cytometry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... ... 2016 , ... In a new case report published today in STEM CELLS ... developed lymphedema after being treated for breast cancer benefitted from an injection of stem ... with this debilitating, frequent side effect of cancer treatment. , Lymphedema refers ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):